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Abstract
To redress gaps in injection drug users' (IDUs) knowledge about hepatitis risk and prevention, we
developed a brief intervention to be delivered to IDUs at syringe exchange programs (SEPs) in
three US cities. Following a month-long campaign in which intervention packets containing novel
injection hygiene supplies and written materials were distributed to every client at each visit,
intervention effectiveness was evaluated by comparing exposed and unexposed participants' self-
reported injection practices. Over one-quarter of the exposed group began using the novel hygiene
supplies which included an absorbent pad ("Safety Square") to stanch blood flow post-injection.
Compared to those unexposed to the intervention, a smaller but still substantial number of
exposed participants continued to inappropriately use alcohol pads post-injection despite exposure
to written messages to the contrary (22.8% vs. 30.0%). It should also be noted that for those
exposed to the intervention, 8% may have misused Safety Squares as part of pre-injection
preparation of their injection site; attention should be paid to providing explicit and accurate
instruction on the use of any health promotion materials being distributed. While this study
indicates that passive introduction of risk reduction materials in injection drug users through
syringe exchange programs can be an economical and relatively simple method of changing
behaviors, discussions with SEP clients regarding explicit instructions about injection hygiene and
appropriate use of novel risk reduction materials is also needed in order to optimize the potential
for adoption of health promotion behaviors. The study results suggest that SEP staff should provide
their clients with brief, frequent verbal reminders about the appropriate use when distributing risk
reduction materials. Issues related to format and language of written materials are discussed.
Background
The "Diffusion of Benefit through Syringe Exchanges Pro-
grams" (DOB) project, a longitudinal study of 584 active
injection drug users (IDUs) in Chicago, IL, Hartford, CT,
and Oakland, CA, used chain referral, ethnographic meth-
ods, semi-structured interviews, and mark-and-recapture
techniques to measure diffusion of risk reduction supplies
and messages from syringe exchange programs (SEPs)
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into the larger IDU community. Preliminary findings
from the main study indicated that many IDUs improp-
erly stanched their blood flow post-injection, and SEP cli-
ents were especially likely to misuse alcohol pads for this
purpose [1]. Since alcohol inhibits coagulation, post-
injection use increases the volume of spilled blood and
leaves wound sites open to potential infection (e.g., hepa-
titis B and C). Based upon these findings, we developed a
brief hepatitis prevention intervention. The intervention
was easily integrated into existing SEP operations with
minimal staff burden. The current sub-study assesses
whether injection hygiene messages included in this brief
intervention were associated with exposure to the inter-
vention and whether the intervention messages and mate-
rials diffused beyond the point of distribution and into
the larger IDU community.
Methods
We conducted the hepatitis intervention sub-study in Year
2 of the four-year longitudinal study. The study design for
the main study, methods, population characteristics, and
injection-associated behaviors are described elsewhere [1-
3]. Recruitment for the main study was via snowball sam-
pling, initiating at the SEPs, and we were thus able to sub-
sequently categorize participants according to the extent
of their SEP use. Participants were interviewed away from
SEP sites, most typically on the streets or at DOB store-
fronts. They were administered a semi-structured inter-
view that assessed pre- and post-injection practices and
familiarity with and use of the SSs. The analyses reported
herein are based solely on the self-reported data collected
from the 208 DOB participants successfully contacted and
interviewed for this sub-study.
The intervention packets consisted of ten small absorbent
pads to be used instead of alcohol pads for post-injection
stanching of blood. These were not commercially availa-
ble, and we named them "Safety Squares" (SSs) to con-
note that their use could reduce injection-associated risk.
The packets also included a palm card (Figure 1) about
hepatitis risk, injection hygiene, and information about
additional resources. It was written at a 10th-grade read-
ing level (approximately equivalent to that of Sports Illus-
trated or Newsweek). SEP staff distributed the intervention
packets to every client visiting the exchange for one
month. Staff were not specifically prohibited from dis-
cussing the materials with clients, but given the limited
time and staffing, it is estimated that less than 10% of cli-
ents spoke with staff about risk reduction and even less
about the hepatitis intervention; conversations were typi-
cally very brief (e.g., "Use alcohol pads before injecting
and Safety Squares after").
Following the month-long distribution period, DOB par-
ticipants were contacted in the field and shown SSs prior
to administering the hepatitis intervention survey. Those
reporting that they had seen one previously and correctly
identified its purpose were classifed as exposed to the
intervention; those incorrectly identifying the SSs or
reporting never having seen it before were considered
'unexposed'.
This sub-study is a secondary analysis of self-reported
data, and we limited our analyses to bivariate analyses
only (Chi-square tests, Fisher's exact tests, t-tests) to exam-
ine differences between exposed and unexposed partici-
pants on sociodemographics and the two injection
hygiene messages targeted in the intervention (i.e., pre-
injection cleaning and post-injecting stanching practices).
Results
A total of 208 participants were interviewed between June
2000 and July 2001. The larger DOB cohort and the sub-
study sample were comparable across sociodemographic
and drug use characteristic except that the sub-study group
had significantly (p < 0.05) fewer Whites (7.2% vs.
23.7%), more African Americans (55.3% vs. 33.8%), and
fewer self-reported histories of hepatitis C infection
(12.9% vs. 87.1%). There were also more participants
from Chicago (57.2% vs. 45.2%) and Hartford (30.8% vs.
22.1%) and fewer from Oakland (12.0% vs. 32.7%) than
in the larger DOB cohort.
The sub-study sample was 59.6% male, 92.8% from
racial/ethnic minority groups, and predominantly heroin
injectors. The mean age was 41.4 years (SD 9.0), and
12.2% had less than a 9th-grade education. On average,
participants had been injecting for 18 years (SD 11.1). In
the previous month, the mean number of injections was
86.9 (SD 69.4), mean injections per syringe was 6.1 (SD
12.6), and 20.9% of participants reported receptive
syringe sharing at least once within the previous 30 days.
No differences were noted in injection behaviors between
the exposed and unexposed groups in the above injection
characteristics.
Compared to the unexposed group, participants who had
seen the SSs were significantly more likely to use SEPs
(57.1% clients vs. 38.2% non-clients; - < 0.01); Exposure
groups also differed with respect to city, and race/ethnicity
(Table 1). Logistic regression analysis revealed that the
likelihood of intervention exposure was greater in Hart-
ford and for Hispanics.
Pre-injection hygiene appeared to be generally adequate,
with most participants stating that they usually used alco-
hol pads (92.5%) or water (32.5%) to clean their injec-
tion site. It is of note that 8.1% of the exposed group also
reported using SSs at pre-injection despite written instruc-
tions to use them only at post-injection. It was unclearHarm Reduction Journal 2009, 6:36 http://www.harmreductionjournal.com/content/6/1/36
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The palm card distributed with a packet of Safety Squares at the intervention sites Figure 1
The palm card distributed with a packet of Safety Squares at the intervention sites.
• Use clean or sterile water for mixing and 
rinsing.  Use different clean or sterile water 
for rinsing than you used for mixing.
• After getting off, press a clean absorbent 
pad (like a safety square) over the injection 
site to stop the blood.  Don’t use alcohol 
pads or fingers to stop the blood.
• Cover the injection site with a bandaid.
IF YOU HAVE HEPATITIS....
• Avoid drinking beer or alcohol.
• Use the absorbent cotton pad only once 
and then throw it away.
WHERE CAN I LEARN MORE ABOUT HEPATITIS?
American Liver Fdn 1-800-GO-LIVER Hepatitis Fdn Int’l 1-800-891-0707
Hepatitis C Connection 1-800-522-HEPC Local # _____________________
PROTECT YOURSELF FROM 
HEPATITIS! AVOID OTHER PEOPLE’S 
BLOOD BY DOING THE FOLLOWING:
• Wash your hands, injection site, and 
tourniquet with soap and water before 
injecting.  Alcohol pads are also good 
for cleaning your skin before injecting.
• Use brand new, never used
syringes, cotton, filters, and cookers.
• Prepare drugs on a cleaned surface.  
If that’s not possible, try using a new 
sheet of paper, newspaper or 
magazine.
WHAT IS HEPATITIS?  WHO IS AT RISK?
• Hepatitis B and C are viruses that attack your liver.  They can cause liver disease and cancer.  
There is a hepatitis B vaccine.  There is no vaccine to prevent hepatitis C, but you can lower 
your risk of getting infected.
• You are at high risk for hepatitis B or C if you inject drugs.
• It is easier to get hepatitis B or C than to get HIV/AIDS in you inject drugs.
• Fresh blood can spread hepatitis B or C.  You can get hepatitis B if you touch dried blood that 
has the virus in it.
• You can be infected with the hepatitis virus for 20 years or more without knowing.
• YOU CAN PROTECT YOURSELF FROM HEPATITIS B AND C INFECTION?
WHERE CAN I LEARN MORE ABOUT HEAPTITIS?
American Liver Fdn 1-800-GO-LIVER Hepatitis Fdn Int’l 1-800-891-0707
Hepatitis C Connection 1-800-522-HEPC Local # _____________________
• Use clean or sterile water for mixing and 
rinsing.  Use different clean or sterile water 
for rinsing than you used for mixing.
• After getting off, press a clean absorbent 
pad (like a safety square) over the injection 
site to stop the blood.  Don’t use alcohol 
pads or fingers to stop the blood.
• Cover the injection site with a bandaid.
IF YOU HAVE HEPATITIS....
• Avoid drinking beer or alcohol.
• Use the absorbent cotton pad only once 
and then throw it away.
WHERE CAN I LEARN MORE ABOUT HEPATITIS?
American Liver Fdn 1-800-GO-LIVER Hepatitis Fdn Int’l 1-800-891-0707
Hepatitis C Connection 1-800-522-HEPC Local # _____________________
PROTECT YOURSELF FROM 
HEPATITIS! AVOID OTHER PEOPLE’S 
BLOOD BY DOING THE FOLLOWING:
• Wash your hands, injection site, and 
tourniquet with soap and water before 
injecting.  Alcohol pads are also good 
for cleaning your skin before injecting.
• Use brand new, never used
syringes, cotton, filters, and cookers.
• Prepare drugs on a cleaned surface.  
If that’s not possible, try using a new 
sheet of paper, newspaper or 
magazine.
WHAT IS HEPATITIS?  WHO IS AT RISK?
• Hepatitis B and C are viruses that attack your liver.  They can cause liver disease and cancer.  
There is a hepatitis B vaccine.  There is no vaccine to prevent hepatitis C, but you can lower 
your risk of getting infected.
• You are at high risk for hepatitis B or C if you inject drugs.
• It is easier to get hepatitis B or C than to get HIV/AIDS in you inject drugs.
• Fresh blood can spread hepatitis B or C.  You can get hepatitis B if you touch dried blood that 
has the virus in it.
• You can be infected with the hepatitis virus for 20 years or more without knowing.
• YOU CAN PROTECT YOURSELF FROM HEPATITIS B AND C INFECTION?
WHERE CAN I LEARN MORE ABOUT HEAPTITIS?
American Liver Fdn 1-800-GO-LIVER Hepatitis Fdn Int’l 1-800-891-0707
Hepatitis C Connection 1-800-522-HEPC Local # _____________________Harm Reduction Journal 2009, 6:36 http://www.harmreductionjournal.com/content/6/1/36
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whether SSs were used to clean the skin with alcohol or
soap and water, although it seems unlikely as these items
were rarely observed during ethnographic activities associ-
ated with the main study.
With respect to post-injection hygiene, 27.8% of those
exposed to the intervention reported usually using the SSs
to stop the flow of blood (Figure 2), suggesting that the
intervention was effective in reaching and changing
behavior in at least one-quarter of participants. However,
regardless of exposure condition, alcohol pads continued
to be commonly mentioned for stanching blood post-
injection (22.8% of exposed vs. 30% of unexposed; p >
0.05).
Finally, we assessed the effectiveness of prevention mes-
sages contained in the palm card. Several of these mes-
sages were consistent with other messages emanating
from the SEPs (e.g., use of clean cookers and water and the
washing of hands). These three messages were all but uni-
formly endorsed by both exposed and unexposed groups
(clean cookers: exposed = 91.3%, unexposed = 95.8%;
clean water: exposed = 92.5%, unexposed = 95.8%; clean
hands: exposed = 87.5%, unexposed = 91.7%). In con-
trast, the exposed group was less likely to endorse mes-
sages about improving injection hygiene via pre-injection
cleaning of tourniquets (38.8% vs. 59.2%; Χ2 4.74, p =
.03), drug preparation surfaces (72.5% vs. 84.4%; Χ2 3.71,
p = .03), or clothes (51.3% vs. 77.1%; Χ2 12.9, p < .0001).
Table 1: Characteristics of Safety Square intervention participants
Variable Unexposed to intervention
n = 118 (%)
Exposed to Intervention
n = 90 (%)
Total
n = 208 (%)
Test statistic, p-value
Site 15.15, p < .001
Chicago 81 (68.6) 38 (42.2) 119 (57.2)
Hartford 25 (21.2) 39 (43.3) 64 (30.8)
Oakland 12 (10.2) 13 (14.4) 25 (12)
Age [mean (SD)] 41.8 (8.5) 41.0 (9.7) 41.4 (9.0) NS
Female 48 (40.7) 36 (40.0) 84 (40.4) NS
Race/ethnicity
Non-Hispanic White 10 (8.5) 5 (5.6) 15 (7.2) 17.29, p < .001*
African American 78 (66.1) 37 (41.1) 115 (55.3)
Hispanic 29 (24.6) 45 (50.0) 74 (35.6)
Other/not reported 1 (.8) 3 (3.3) 4 (1.9)
Less than high school education 52 (44.4) 52 (57.8) 104 (50.2) NS
Earning <$1000 per month 77 (65.2) 60 (66.7) 137 (65.9) NS
SEP user 24 (20) 32 (35.6) 56 (26.9) 6.0, p = .01
Drug treatment (Ever) 83 (71.6) 70 (79.5) 153 (75) NS
Ever tested for HIV 82 (92.1) 108 (92.3) 190 (92.2) NS
Diagnosed HIV+ 16 (14.7) 11 (13.3) 27 (14.1) NS
History of
Hepatitis B 15 (13) 11 (13.1) 26 (13.1) NS
Hepatitis C 11 (9.5) 15 (17.4) 26 (12.9) NS
Hepatitis of unknown etiology 9 (7.9) 14 (15.6) 23 (11.3) NS
Hepatitis B vaccinated (ever) 31 (27.7) 22 (27.8) 53 (27.7) NS
Heroin as the drug injected most often in 
past 30 days
80 (67.8) 66 (73.3) 146 (70.2) NS
* Exposure associated with Hispanic ethnicity p = .06 (reference = Non-Hispanic white and all other groups)Harm Reduction Journal 2009, 6:36 http://www.harmreductionjournal.com/content/6/1/36
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Discussion
Over one quarter of those exposed to the intervention
reported adopting use of SSs, providing preliminary evi-
dence that low-intensity interventions can benefit the
public health. Although those who were exposed to the
intervention were significantly more likely to be SEP cli-
ents, non-client exposure rates suggested that some diffu-
sion of the intervention occurred into the larger IDU
community.
However, the accompanying written material was not so
well received. The palm card's 10th grade reading level may
have been too high. Although we know of no assessments
of reading levels among IDU populations, one possibility
is that the palm card was not easily comprehended. The
readability scores of other materials designed for IDUs
have generally been lower, around 7th grade [4]. It may be
that the formatting of printed materials may be as impor-
tant as their content. Inappropriate use of SSs may have
been less likely to occur if the message had appeared ear-
lier in the palm card and/or the number of unique mes-
sages had been fewer.
The findings also suggest that, while passive distribution
of risk reduction materials may be associated with subse-
quent adoption of healthier behaviors, such campaigns
may not be sufficient if not accompanied by frank dia-
logue and explicit instructions about appropriate use of
these materials. Injectors may be unaware of the anticoag-
ulation property of alcohol, instead believing that post-
injection swabbing with alcohol protects against blood-
borne infections. SEPs routinely distribute health promo-
tion brochures, and customers may become inured or
confused by the plethora of information. Communica-
tion problems continue to plague HIV risk reduction
efforts: condom misuse persists despite package inserts
and condom use campaigns [5,6]. Our findings are con-
sistent with reports of unintended consequences of SEP-
Proportion of participants reporting their method of stanching blood post-injection by exposure group Figure 2
Proportion of participants reporting their method of stanching blood post-injection by exposure group. Exposed 
refers to study participants who reported having seen a Safety Square and correctly indentified its purpose. Exposed minus SS 
reports refers to study participants in the exposed group not reporting Safety Squares as the most frequent material used to 
stanch blood post-injection. This group represents people exposed to the intervention who may exhibit behavior change short 
of primary reliance upon Safety Squares. Unexposed refers to study participants who incorrectly identified the Safety Squares or 
reported never having seen it before.
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based HIV prevention activities [7] and suggest that, along
with continued distribution of risk reduction materials,
risk reduction staff should be encouraged to instruct their
clients - briefly and often - about the proper use of these
materials.
Study limitations such as non-random sampling and
social desirability factors may reduce the potential gener-
alizability of the findings. However, at the time of the hep-
atitis intervention sub-study our research staff had long-
standing relationships (>1 year) with participants, having
observed and interacted with them away from the SEPs;
social desirability factors are therefore considered to be
minimal, and differences in exposure across the three sites
could be due to structural differences among SEPs such as
location, hours of operation, legal status, between-city dif-
ferences in the dynamics of injecting drug use, syringe
availability, or other reasons [2]. It is also possible that the
Safety Square and the palm card could have been uncou-
pled. This may have resulted in some participants having
been exposed to only one part of the intervention (i.e., the
Safety Square). We therefore have limited evidence to sug-
gest that the intervention worked, and a more rigorously
verifiable definition of exposure would be warranted in
any large scale evaluation of intervention efficacy.
In conclusion, the brief intervention that was imple-
mented in this study resulted in a modest uptake by the
injecting community, and intervention messages and
materials diffused beyond the SEPS from which they orig-
inated. However, when developing written material, its
content and format should be carefully reviewed and
beta-tested to ensure that it is clear, understandable, and
acceptable to targeted audience. Finally, while these writ-
ten materials are useful in disseminating harm reduction
messages, they should never supplant frank and open dis-
cussions of harm reduction strategies with end-users.
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